Literature DB >> 2553102

Enhancement of c-erbA proto-oncogene expression by glucocorticoid hormones in S49.1 lymphoma cells.

M Maroder1, A Vacca, I Screpanti, E Petrangeli, L Frati, A Gulino.   

Abstract

The modifications of the mRNA levels of the c-myc and c-erbA proto-oncogenes during the dexamethasone-induced decrease of S49.1 cell proliferation have been studied. The levels of c-myc mRNA decreased significantly between 3 and 18 h after dexamethasone (1 microM) treatment. In contrast, a significant increase in the levels of a 2.6 kb c-erbA mRNA was observed between 6 and 18 h after hormone treatment. Cycloheximide treatment of S49.1 cells increased the levels of c-erbA RNA and overcome the enhancing effect of dexamethasone on the expression of this proto-oncogene, suggesting that ongoing protein synthesis is necessary to elicit this hormone effect. The associated decrease of cell proliferation and changes in c-myc and c-erbA mRNA levels after dexamethasone treatment suggest that such oncogenes might be involved in the dexamethasone-mediated control of lymphoid cell growth.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2553102     DOI: 10.1016/0167-4781(89)90100-0

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  2 in total

1.  Post-transcriptional control of c-myc proto-oncogene expression by glucocorticoid hormones in human T lymphoblastic leukemic cells.

Authors:  M Maroder; S Martinotti; A Vacca; I Screpanti; E Petrangeli; L Frati; A Gulino
Journal:  Nucleic Acids Res       Date:  1990-03-11       Impact factor: 16.971

2.  Glucocorticoid receptor-mediated suppression of the interleukin 2 gene expression through impairment of the cooperativity between nuclear factor of activated T cells and AP-1 enhancer elements.

Authors:  A Vacca; M P Felli; A R Farina; S Martinotti; M Maroder; I Screpanti; D Meco; E Petrangeli; L Frati; A Gulino
Journal:  J Exp Med       Date:  1992-03-01       Impact factor: 14.307

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.